Spots Global Cancer Trial Database for Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma
Official Title: Therapeutic Strategy Guided by PET-TDM for Patients With Grade I or Metastatic Seminoma
Study ID: NCT01887340
Conditions
Study Description
Brief Summary: The purpose of the study is to evaluate the ration of patients getting an lighten therapeutic strategy after 18F-fluoro-désoxyglucose positron emission tomography (PET-TDM) in grade I (cohort 1) or metastatic (cohort 2) seminoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Gustave Roussy, Villejuif, Val de Marne, France
Contact Details
Name: Yohann LORIOT, MD
Affiliation: Gustave Roussy, Cancer Campus, Grand Paris
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
